Breast cancer (BC), which accounts for 27 percent of all cancers in women in India, is the top malignancy among women. The increasing prevalence of breast cancer and, more crucially, the higher mortality rates among patients suffering from breast cancer are causing political and public health concerns. The lack of awareness and screening leading to the late presentation at advanced stages is one of the main causes of fatalities from high breast cancer. The current research, therefore, aims to investigate women in a low socio-economic neighborhood of Mumbai in terms of their understanding of breast cancer symptoms and risk factors.
In Prabhadevi, Mumbai, a cross-sectional study has been undertaken. 480 women aged 18–55 years collected primary data. In order to collect quantitative data concerning the awareness, signs, and signs of breast cancer, the structured questionnaire was utilized. To detect the social-demographic differences in breast cancer awareness among women, bivariate and multivariate regression techniques were applied. The analysis has shown that women living in India, regardless of their socio-economic and educational status, have low levels of literacy on cancer risk factors. National and national awareness efforts, involving several stakeholders in society and the health care system, are urgently needed in order to increase cancer literacy in India. In addition to the standard mammography, Digital Breast tomosynthesis (DBT), and early-stage breast biopsy procedures, molecular diagnostic developments, and therapies have resulted in numerous noninvasive predictive biomarker tests to diagnose breast cancer. Ki67 is a cell-proliferation protein biomarker for several cancer types. Higher marker levels correspond to faster growth of the tumor. HER2, cytokeratin (CK), CK7, CK8, CK18, and CK19 are other biomarkers that signal breast carcinomas and high tumor grades.
Within Rashtriya Arogya Nidhi (RAN) the government established the Indischen Minister of Health’s Cancer Patient Fund (HMCPF) in 2009, in order to provide and hasten the funding for the patients in need. This scheme, which covers the 27 Regional Cancer Centers (RCC) across the different sections of India, has assigned cash support between 2 lakh and 5 lakh rupees